F. Tas Et Al. , "Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience," MEDICAL ONCOLOGY , vol.23, no.4, pp.471-477, 2006
Tas, F. Et Al. 2006. Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience. MEDICAL ONCOLOGY , vol.23, no.4 , 471-477.
Tas, F., Kurul, S., Camlica, H., & Topuz, E., (2006). Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience. MEDICAL ONCOLOGY , vol.23, no.4, 471-477.
Tas, Faruk Et Al. "Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience," MEDICAL ONCOLOGY , vol.23, no.4, 471-477, 2006
Tas, Faruk Et Al. "Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience." MEDICAL ONCOLOGY , vol.23, no.4, pp.471-477, 2006
Tas, F. Et Al. (2006) . "Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience." MEDICAL ONCOLOGY , vol.23, no.4, pp.471-477.
@article{article, author={Faruk TAŞ Et Al. }, title={Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience}, journal={MEDICAL ONCOLOGY}, year=2006, pages={471-477} }